Conyers provided British Virgin Islands and Cayman Islands legal advice to Fangzhou Inc. (“Fangzhou”) in connection with its successful initial public offering on the Main Board of the Hong Kong Stock Exchange Limited raising approximately HK$198 million.

Fangzhou is the largest online chronic disease management platform in China commencing business with a focus on chronic disease management to address the needs of patients with chronic diseases. They provide comprehensive medical services and online retail pharmacy services.

Partner Richard Hall, Angie Chu, Counsel Alexander Doyle and Associate Noel Ng of Conyers’ Hong Kong office advised on the matter, working alongside Kirkland & Ellis.

Stay current with our latest legal insights and subscribe today